NO176319C - Analogifremgangsmåte for fremstilling av terapeutisk aktive furanderivater - Google Patents

Analogifremgangsmåte for fremstilling av terapeutisk aktive furanderivater

Info

Publication number
NO176319C
NO176319C NO892936A NO892936A NO176319C NO 176319 C NO176319 C NO 176319C NO 892936 A NO892936 A NO 892936A NO 892936 A NO892936 A NO 892936A NO 176319 C NO176319 C NO 176319C
Authority
NO
Norway
Prior art keywords
preparation
therapeutically active
analogous process
furan derivatives
active furan
Prior art date
Application number
NO892936A
Other languages
English (en)
Norwegian (no)
Other versions
NO176319B (no
NO892936L (no
NO892936D0 (no
Inventor
John Watson Clitherow
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888817098A external-priority patent/GB8817098D0/en
Priority claimed from GB898904686A external-priority patent/GB8904686D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NO892936D0 publication Critical patent/NO892936D0/no
Publication of NO892936L publication Critical patent/NO892936L/no
Publication of NO176319B publication Critical patent/NO176319B/no
Publication of NO176319C publication Critical patent/NO176319C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO892936A 1988-07-18 1989-07-17 Analogifremgangsmåte for fremstilling av terapeutisk aktive furanderivater NO176319C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB888817098A GB8817098D0 (en) 1988-07-18 1988-07-18 Chemical compounds
GB898904686A GB8904686D0 (en) 1989-03-01 1989-03-01 Chemical compounds

Publications (4)

Publication Number Publication Date
NO892936D0 NO892936D0 (no) 1989-07-17
NO892936L NO892936L (no) 1990-01-19
NO176319B NO176319B (no) 1994-12-05
NO176319C true NO176319C (no) 1995-03-15

Family

ID=26294175

Family Applications (2)

Application Number Title Priority Date Filing Date
NO892936A NO176319C (no) 1988-07-18 1989-07-17 Analogifremgangsmåte for fremstilling av terapeutisk aktive furanderivater
NO1998007C NO1998007I1 (no) 1988-07-18 1998-02-05 Ranitidin-vismutcitrat

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO1998007C NO1998007I1 (no) 1988-07-18 1998-02-05 Ranitidin-vismutcitrat

Country Status (35)

Country Link
US (1) US5008256A (sv)
JP (1) JP2523185B2 (sv)
KR (1) KR0122598B1 (sv)
CN (1) CN1022626C (sv)
AT (1) AT398200B (sv)
AU (1) AU632052B2 (sv)
BE (1) BE1003254A5 (sv)
CA (1) CA1332610C (sv)
CH (1) CH679582A5 (sv)
CY (1) CY1650A (sv)
DE (1) DE3923638C2 (sv)
DK (1) DK168381B1 (sv)
EG (1) EG19368A (sv)
ES (1) ES2014175A6 (sv)
FI (1) FI90538C (sv)
FR (1) FR2634122B1 (sv)
GB (1) GB2220937B (sv)
GR (1) GR1000431B (sv)
HK (1) HK61392A (sv)
HU (2) HU206104B (sv)
IE (1) IE61076B1 (sv)
IL (1) IL91005A (sv)
IT (1) IT1231481B (sv)
LU (2) LU88722I2 (sv)
MX (1) MX174145B (sv)
MY (1) MY104055A (sv)
NL (2) NL192604C (sv)
NO (2) NO176319C (sv)
NZ (1) NZ229958A (sv)
PL (1) PL162391B1 (sv)
PT (1) PT91188B (sv)
SE (1) SE468715B (sv)
SG (1) SG51992G (sv)
YU (1) YU47021B (sv)
ZW (1) ZW8689A1 (sv)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL85472A (en) * 1987-03-09 1991-06-30 Procter & Gamble Pharmaceutical compositions for treating gastrointestinal disorders
ATE81011T1 (de) * 1987-03-09 1992-10-15 Procter & Gamble Zusammensetzungen und ihre verwendung zur behandlung von magen-darmstoerungen.
AU641903B2 (en) * 1988-10-26 1993-10-07 Glaxo Group Limited Carboxylic acid derivatives
GB9004328D0 (en) * 1990-02-27 1990-04-25 Glaxo Group Ltd Chemical compounds
GB9009240D0 (en) * 1990-04-25 1990-06-20 Glaxo Group Ltd Chemical compounds
GB9009437D0 (en) * 1990-04-26 1990-06-20 Glaxo Group Ltd Chemical compounds
ES2084174T3 (es) * 1990-07-20 1996-05-01 Tillotts Pharma Ag Productos y procesos para el tratamiento del conducto alimentario.
GB9019875D0 (en) * 1990-09-11 1990-10-24 Glaxo Group Ltd Pharmaceutical compositions
US5192752A (en) * 1991-01-14 1993-03-09 The Procter & Gamble Company Swallowable pharmaceutical compositions containing colloidal bismuth subcitrate
US5128140A (en) * 1991-01-14 1992-07-07 The Procter & Gamble Company Swallowable pharmaceutical compositions
GB9120131D0 (en) * 1991-09-20 1991-11-06 Glaxo Group Ltd Medicaments
ES2130152T3 (es) * 1991-12-06 1999-07-01 Glaxo Group Ltd Medicamentos para tratar dolencias inflamatorias o para analgesia que contienen un nsaid y ranitidina/citrato de bismuto.
AU1671295A (en) * 1994-12-19 1996-07-10 Lauteral Limited Combinations of ranitidine hydrochloride-form 1 and bismuth compounds
HUP9900428A2 (hu) * 1995-01-26 1999-06-28 Nycomed Imaging A/S Bizmutvegyületek, ezeket tartalmazó diagnosztikai kontrasztanyag, ennek alkalmazása és ezt tartalmazó gyógyászati készítmény
GB9501560D0 (en) 1995-01-26 1995-03-15 Nycomed Imaging As Contrast agents
EP1035192A1 (de) * 1999-01-26 2000-09-13 Stefan Graichen Additiv für einen Kühlschmierstoff
CN1102585C (zh) * 1999-04-28 2003-03-05 常州兰陵制药有限公司 雷尼替丁枸橼酸铋盐的制备方法
US20060100271A1 (en) * 2004-11-08 2006-05-11 Keith Whitehead Stabilized aqueous ranitidine compositions
CN100402514C (zh) * 2006-08-01 2008-07-16 丽珠医药集团股份有限公司 一种制备枸橼酸铋雷尼替丁的方法
AU2007216671B2 (en) * 2007-07-09 2009-07-16 Cypress Pharmaceutical, Inc. Pleasant-tasting ranitidine formulation
CN102408398B (zh) * 2011-09-20 2012-12-05 江苏汉斯通药业有限公司 枸橼酸铋雷尼替丁的制备方法
US9731999B2 (en) 2011-09-23 2017-08-15 Iqbal Gill Chemical admixtures for hydraulic cements
ES2426539B1 (es) * 2012-04-18 2014-09-09 Dr Healthcare España, S. L. Uso de la diaminooxidasa para el tratamiento o la prevención del trastorno por deficit de atencion con hiperactividad (adhd)
CN103896888B (zh) * 2014-03-28 2015-11-18 常州兰陵制药有限公司 枸橼酸铋雷尼替丁的制备方法
EP2929884A1 (en) 2014-04-11 2015-10-14 Sanovel Ilac Sanayi ve Ticaret A.S. Pharmaceutical combinations of dabigatran and h2-receptor antagonists
EP2942058A1 (en) 2014-05-09 2015-11-11 Sanovel Ilac Sanayi ve Ticaret A.S. Pharmaceutical combinations of rivaroxaban and H2-receptor antagonists
CN107382921A (zh) * 2017-07-28 2017-11-24 常州兰陵制药有限公司 制备枸橼酸铋雷尼替丁的方法
EP4196793A1 (en) 2020-08-11 2023-06-21 Université de Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1565966A (en) * 1976-08-04 1980-04-23 Allen & Hanburys Ltd Aminoalkyl furan derivatives
FR2531706A1 (fr) * 1982-08-13 1984-02-17 Sanofi Sa Benzamides, leurs sels, procede pour leur preparation et compositions pharmaceutiques les renfermant
BE905235A (fr) * 1986-08-05 1986-12-01 Hasunor Ag Ascorbates antagonistes des recepteurs h2 et leur procede de preparation.
IT1215325B (it) * 1987-01-07 1990-02-08 Barisintex Sa Composti antagonisti di recettori -h2 e procedimento per la loro preparazione.
ATE81011T1 (de) * 1987-03-09 1992-10-15 Procter & Gamble Zusammensetzungen und ihre verwendung zur behandlung von magen-darmstoerungen.
IL85472A (en) * 1987-03-09 1991-06-30 Procter & Gamble Pharmaceutical compositions for treating gastrointestinal disorders
DE3710462A1 (de) * 1987-03-30 1988-10-13 Heumann Pharma Gmbh & Co Pharmazeutische zubereitung zur behandlung von erkrankungen des magen-darm-traktes
GB9004328D0 (en) * 1990-02-27 1990-04-25 Glaxo Group Ltd Chemical compounds
GB9009437D0 (en) * 1990-04-26 1990-06-20 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
FI90538C (sv) 1994-02-25
HK61392A (en) 1992-08-21
IT1231481B (it) 1991-12-07
CN1039419A (zh) 1990-02-07
JP2523185B2 (ja) 1996-08-07
AU632052B2 (en) 1992-12-17
NL970046I2 (nl) 1998-04-01
NO176319B (no) 1994-12-05
HUT52082A (en) 1990-06-28
SE8902550D0 (sv) 1989-07-17
BE1003254A5 (fr) 1992-02-11
IL91005A (en) 1994-10-07
PL162391B1 (pl) 1993-10-30
DK351789D0 (da) 1989-07-17
HU211173A9 (en) 1995-11-28
YU142789A (en) 1991-04-30
FI90538B (sv) 1993-11-15
NO892936L (no) 1990-01-19
DE3923638C2 (de) 1995-11-23
DK168381B1 (da) 1994-03-21
GB8916288D0 (en) 1989-08-31
ZW8689A1 (en) 1990-02-21
GB2220937A (en) 1990-01-24
FI893448A (sv) 1990-01-19
LU87557A1 (fr) 1990-07-24
CH679582A5 (sv) 1992-03-13
CN1022626C (zh) 1993-11-03
NL970046I1 (nl) 1998-03-02
NO892936D0 (no) 1989-07-17
IE892309L (en) 1990-01-18
FR2634122A1 (fr) 1990-01-19
KR910002826A (ko) 1991-02-26
MX174145B (es) 1994-04-25
ATA172889A (de) 1994-02-15
SE8902550L (sv) 1990-01-19
GB2220937B (en) 1991-11-27
ES2014175A6 (es) 1990-06-16
GR1000431B (el) 1992-07-30
EG19368A (en) 1995-02-28
AT398200B (de) 1994-10-25
DK351789A (da) 1990-01-19
KR0122598B1 (ko) 1997-11-13
DE3923638A1 (de) 1990-03-01
LU88722I2 (fr) 1996-08-23
CA1332610C (en) 1994-10-18
NL192604B (nl) 1997-07-01
FI893448A0 (sv) 1989-07-17
CY1650A (en) 1992-12-11
IL91005A0 (en) 1990-02-09
NZ229958A (en) 1991-09-25
SG51992G (en) 1992-07-24
AU3817889A (en) 1990-01-18
NL8901840A (nl) 1990-02-16
IT8948196A0 (it) 1989-07-17
HU206104B (en) 1992-08-28
PT91188A (pt) 1990-02-08
NL192604C (nl) 1997-11-04
NO1998007I1 (no) 1998-02-05
SE468715B (sv) 1993-03-08
IE61076B1 (en) 1994-09-21
YU47021B (sh) 1994-11-15
GR890100454A (en) 1990-06-27
JPH02117684A (ja) 1990-05-02
MX16829A (es) 1993-10-01
US5008256A (en) 1991-04-16
FR2634122B1 (fr) 1993-11-19
MY104055A (en) 1993-10-30
PT91188B (pt) 1995-03-01

Similar Documents

Publication Publication Date Title
NO176319C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive furanderivater
FI96861C (sv) Förfarande för framställning av terapeutiskt aktiva substituerade indolylpyrrolderivat
NO177387C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive imidazo-kondenserte, 6-leddede, heterocykliske forbindelser
NO174467C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive kromanderivater
NO176759C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 3-substituerte-2-oksindol-derivater
NO175478C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive diazepin-derivater
NO178068C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive tiazolidindionderivater
NO178619C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive di-t-butylfenoler
NO176275C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive pyridazinonderivater
NO178543C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive benzopyranderivater
NO176713C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 4-aminopyridinderivater
FI96601C (sv) Förfarande för framställning av terapeutiskt aktiva tetrazolderivat
NO173334C (no) Analogifremgangsm}te for fremstilling av terapeutisk aktive alkylaminoalkylenderivater 2H-1-benzopyraner
NO174959C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive N-aminobutyl-N-fenyl-arylamidderivater
FI93444B (sv) Förfarande för framställning av terapeutiskt aktiva dihydropyridinföreningar
NO174391C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive kromanderivater
NO173784C (no) Anaslogifremgangsmaate for fremstilling av terapeutisk aktive tieno-tri-azolo-diazepinderivater
NO178698C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive glycerolderivater
NO174422C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive kromanderivater
NO176099C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 4-(2-okso-3-pyridyl)-kromanderivater
FI903077A0 (sv) Förfarande för framställning av terapeutiskt aktiva R(-)-3-kinuklidinolderivat
NO174463C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive pyrrolidinderivater
NO173606C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tieno- triazolo-diazepin-derivater
FI880190A0 (sv) Förfarande för framställning av terapeutiskt verksamma tetrahydrofuranderivat
NO176105C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive peptidderivater

Legal Events

Date Code Title Description
MK1K Patent expired